22-36320164-G-A
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002473.6(MYH9):c.1012+56C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.55 in 1,611,550 control chromosomes in the GnomAD database, including 253,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002473.6 intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 17Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing lossInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- May-Hegglin anomalyInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MYH9 | NM_002473.6 | c.1012+56C>T | intron_variant | Intron 9 of 40 | ENST00000216181.11 | NP_002464.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.476  AC: 72096AN: 151522Hom.:  19090  Cov.: 32 show subpopulations 
GnomAD4 exome  AF:  0.558  AC: 814043AN: 1459910Hom.:  234843   AF XY:  0.553  AC XY: 401770AN XY: 726348 show subpopulations 
Age Distribution
GnomAD4 genome  0.476  AC: 72105AN: 151640Hom.:  19090  Cov.: 32 AF XY:  0.473  AC XY: 35043AN XY: 74060 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Benign:2 
- -
- -
not specified    Benign:1 
This variant is classified as Benign based on local population frequency. This variant was detected in 86% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 80. Only high quality variants are reported. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at